Skip to main content

Morphic Holding, Inc.

MORFDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001679363

Morphic Holding, Inc. was delisted in 2024; its insiders filed their last Form 4 on Aug 21, 2024; 136 institutions reported holding it in 13F filings for Q2 2024, worth $1.54B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Morphic Holding, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Morphic Holding, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Morphic Holding, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Edwards MartinDirector0Aug 21, 20240
Springer Timothy ADirector, 10% Owner0IndirectAug 20, 20240
Bischofberger Norbert WDirector–Aug 20, 20240
Slattery Joseph PDirector0Aug 20, 20240
Christensen GustavDirector0Aug 20, 20240
Nashat AmirDirector0IndirectAug 20, 20240
Farrell Robert E JrSVP Finance and CAO0Aug 20, 20240
Schegerin MarcCFO and COO0Aug 20, 20240
Tipirneni Praveen P.President and CEO0IndirectAug 20, 20240
DeVaul WilliamGeneral Counsel and Secretary0Aug 20, 20240
Rogers BrucePRESIDENT0Aug 20, 20240
Gray SusannahDirector–Aug 20, 20240
Cooper Simon PeterCMO–Aug 20, 20240
Nanda NishaDirector–Jun 5, 20240
Linde PeterChief Medical Officer11,272Sep 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 10, 2024 (view filing)Jul 82 daysRogers BrucePRESIDENTSSale−20.0K$55.79−$1.12M−11.8%149.9K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysSchegerin MarcCFO and COOSSale−43.9K$55.80−$2.45M−53.7%37.9K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysTipirneni Praveen P.President and CEOSSale−21.6K$55.79−$1.20M−33.7%42.5K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysFarrell Robert E JrSVP Finance and CAOSSale−30.3K$55.80−$1.69M−68.7%13.8K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysDeVaul WilliamGeneral Counsel and SecretarySSale−10.0K$55.79−$557.9K−30.3%23.0K after10b5-1
Jan 17, 2024 (view filing)Jan 161 dayTipirneni Praveen P.CEOSSale−13.9K$27.49−$382.7K−24.9%42.0K after
Jan 17, 2024 (view filing)Jan 161 daySchegerin MarcCFO and COOSSale−6.04K$27.49−$166.1K−13.9%37.5K after
Jan 17, 2024 (view filing)Jan 161 dayRogers BrucePresidentSSale−6.31K$27.49−$173.6K−4.3%142.0K after
Jan 17, 2024 (view filing)Jan 161 dayFarrell Robert E JrSVP Finance and CAOSSale−5.09K$27.49−$139.9K−12.7%35.0K after
Jan 17, 2024 (view filing)Jan 161 dayDeVaul WilliamGeneral Counsel and SecretarySSale−4.51K$27.49−$124.0K−16.4%23.0K after
Nov 15, 2023 (view filing)Nov 132 daysEdwards MartinDirectorPPurchase+2.38K$20.54+$48.8KNew position2.38K after
Nov 14, 2023 (view filing)Nov 131 daySlattery Joseph PDirectorPPurchase+2.40K$20.60+$49.4K+36.0%9.07K after
Sep 8, 2023 (view filing)Sep 71 daySchegerin MarcCFO and COOSSale−20.0K$54.34−$1.09M−45.3%24.1K after2 lots
Aug 3, 2023 (view filing)Aug 12 daysTipirneni Praveen P.President and CEOSSale−3.60K$57.04−$205.2K−20.5%13.9K after3 lots
Jul 6, 2023 (view filing)Jul 33 daysTipirneni Praveen P.President and CEOSSale−3.60K$57.04−$205.2K−20.5%13.9K after
Jun 14, 2023 (view filing)Jun 122 daysTipirneni Praveen P.President and CEOSSale−840$63.01−$52.9K−5.7%13.9K after
Jun 9, 2023 (view filing)Jun 72 daysDeVaul WilliamGeneral Counsel and SecretarySSale−7.76K$60.05−$465.7K−36.8%13.3K after
Jun 2, 2023 (view filing)Jun 11 dayTipirneni Praveen P.President and CEOSSale−3.60K$57.14−$205.5K−20.5%13.9K after2 lots
May 25, 2023 (view filing)May 232 daysFarrell Robert E JrSVP Finance and CAOSSale−10.0K$60.00−$600.0K−29.7%23.7K after
May 25, 2023 (view filing)May 23-242 daysDeVaul WilliamGeneral Counsel and SecretarySSale−3.90K$60.03−$234.2K−15.6%21.1K after2 lots
May 5, 2023 (view filing)May 32 daysTipirneni Praveen P.President and CEOSSale−3.60K$51.11−$183.8K−20.5%13.9K after
May 4, 2023 (view filing)May 31 daySpringer Timothy ADirector, 10% OwnerPPurchase+1.05M$45.00+$47.3M+61.1%2.77M after
Apr 27, 2023 (view filing)Apr 252 daysFarrell Robert E JrSVP Finance and CAOSSale−10.0K$54.71−$547.1K−45.0%12.2K after
Apr 27, 2023 (view filing)Apr 252 daysTipirneni Praveen P.President and CEOSSale−25.2K$53.40−$1.34M−64.4%13.9K after
Apr 27, 2023 (view filing)Apr 252 daysSchegerin MarcCFO and COOSSale−50.0K$54.71−$2.74M−67.4%24.1K after
Apr 27, 2023 (view filing)Apr 252 daysRogers BrucePresidentSSale−30.0K$53.40−$1.60M−20.4%117.1K after
Apr 21, 2023 (view filing)Apr 201 dayFarrell Robert E JrSVP Finance and CAOSSale−10.0K$45.00−$450.0K−45.0%12.2K after10b5-1
Apr 19, 2023 (view filing)Apr 172 daysFarrell Robert E JrSVP Finance and CAOSSale−20.0K$41.25−$825.0K−90.0%2.22K after2 lots10b5-1
Apr 19, 2023 (view filing)Apr 172 daysRogers BrucePresidentSSale−10.0K$40.35−$403.5K−7.9%117.1K after10b5-1
Mar 9, 2023 (view filing)Mar 72 daysSchegerin MarcCFO and COOSSale−50.0K$45.00−$2.25M−74.5%17.1K after
Feb 16, 2023 (view filing)Feb 142 daysRogers BrucePresidentSSale−10.0K$40.09−$400.9K−7.9%116.2K after
Jan 18, 2023 (view filing)Jan 144 daysDeVaul WilliamGeneral Counsel and SecretarySSale−1.17K$30.63−$35.8K−4.7%23.7K after
Jan 18, 2023 (view filing)Jan 144 daysFarrell Robert E JrSVP Finance and CAOSSale−1.25K$30.63−$38.2K−5.3%22.2K after
Jan 18, 2023 (view filing)Jan 144 daysRogers BrucePresidentSSale−1.78K$30.63−$54.5K−1.5%116.2K after
Jan 18, 2023 (view filing)Jan 144 daysSchegerin MarcCFO and COOSSale−1.67K$30.63−$51.2K−9.3%16.2K after
Jan 18, 2023 (view filing)Jan 144 daysTipirneni Praveen P.President and CEOSSale−4.03K$30.63−$123.3K−24.1%12.7K after
Apr 1, 2022 (view filing)Apr 1Same dayRogers BruceChief Scientific OfficerSSale−10.0K$41.03−$410.3K−8.9%102.9K after2 lots
Oct 28, 2021 (view filing)Oct 262 daysSchegerin MarcCFO and COOSSale−37$60.00−$2.22K−0.6%6.53K after
Oct 15, 2021 (view filing)Oct 13-152 daysSchegerin MarcCFO and COOSSale−29.5K$60.02−$1.77M−81.9%6.53K after3 lots
Sep 17, 2021 (view filing)Sep 161 dayLinde PeterChief Medical OfficerSSale−4.00K$66.51−$266.0K−26.2%11.3K after3 lots
Sep 14, 2021 (view filing)Sep 10-134 daysFarrell Robert E JrSVP Finance and CAOSSale−12.9K$65.11−$840.4K−56.3%10.0K after2 lots
Sep 13, 2021 (view filing)Sep 9-134 daysRogers BruceChief Scientific OfficerSSale−40.0K$62.00−$2.48M−30.8%89.9K after5 lots
Aug 20, 2021 (view filing)Aug 18-202 daysSpringer Timothy ADirector, 10% OwnerPPurchase+74.9K$56.23+$4.21M+8.9%912.2K after7 lots